OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association between Semaglutide and Non-Arteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Real-World Study
Chien-Chih Chou, Ssu-Yu Pan, Yi‐Jing Sheen, et al.
Ophthalmology (2024)
Closed Access | Times Cited: 17
Chien-Chih Chou, Ssu-Yu Pan, Yi‐Jing Sheen, et al.
Ophthalmology (2024)
Closed Access | Times Cited: 17
Showing 17 citing articles:
The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy
Nadia J. Abbass, Raya Nahlawi, Jacqueline K. Shaia, et al.
American Journal of Ophthalmology (2025)
Open Access | Times Cited: 3
Nadia J. Abbass, Raya Nahlawi, Jacqueline K. Shaia, et al.
American Journal of Ophthalmology (2025)
Open Access | Times Cited: 3
GLP-1 RAs and Nonarteritic Anterior Ischemic Optic Neuropathy—Making Sense of the Data
Mahyar Etminan, Mohit Sodhi, David Maberley
JAMA Ophthalmology (2025)
Closed Access | Times Cited: 2
Mahyar Etminan, Mohit Sodhi, David Maberley
JAMA Ophthalmology (2025)
Closed Access | Times Cited: 2
Are synthetic incretins associated with ischaemic optic neuropathy?
Victoria Gregory, Susan P. Mollan
Eye (2025)
Closed Access | Times Cited: 2
Victoria Gregory, Susan P. Mollan
Eye (2025)
Closed Access | Times Cited: 2
Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study
Emma Simonsen, Lars Christian Lund, Martin Ernst, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 2
Emma Simonsen, Lars Christian Lund, Martin Ernst, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 2
Semaglutide and non‐arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association
A Amini, Steffen Hamann, Michael Larsen
Acta Ophthalmologica (2025)
Open Access | Times Cited: 1
A Amini, Steffen Hamann, Michael Larsen
Acta Ophthalmologica (2025)
Open Access | Times Cited: 1
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study
Emma Simonsen, Lars Christian Lund, Martin Ernst, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Emma Simonsen, Lars Christian Lund, Martin Ernst, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Semaglutide, type 2 diabetes, and the risk of nonarteritic anterior ischemic optic neuropathy
Fernando Korn Malerbi, Marcello Casaccia Bertoluci
International Journal of Retina and Vitreous (2025) Vol. 11, Iss. 1
Open Access
Fernando Korn Malerbi, Marcello Casaccia Bertoluci
International Journal of Retina and Vitreous (2025) Vol. 11, Iss. 1
Open Access
Semaglutide and Risk of NAION—Additional Insights
Joseph F. Rizzo, Jimena Tatiana Hathaway
JAMA Ophthalmology (2025)
Closed Access
Joseph F. Rizzo, Jimena Tatiana Hathaway
JAMA Ophthalmology (2025)
Closed Access
Re: Chou et al.: Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study (Ophthalmology. 2025;132:381-388)
Flora Lum
Ophthalmology (2025)
Closed Access
Flora Lum
Ophthalmology (2025)
Closed Access
Conflicting Results—Need for More Transparent and Reproducible Research
Cindy X. Cai, Michelle R. Hribar, Akihiko Nishimura
JAMA Ophthalmology (2025)
Closed Access
Cindy X. Cai, Michelle R. Hribar, Akihiko Nishimura
JAMA Ophthalmology (2025)
Closed Access
Non arteritic ischemic optic neuropathy in a patient taking semaglutide: Is there a relation? A case report and a review of the literature
Martina Maceroni, Paola Sasso, Matteo Giarletti, et al.
European Journal of Ophthalmology (2025)
Closed Access
Martina Maceroni, Paola Sasso, Matteo Giarletti, et al.
European Journal of Ophthalmology (2025)
Closed Access
Re: Chou et al.: Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study (Ophthalmology. 2025:132:381-388)
Hui Zhu, Kun Zhao
Ophthalmology (2025)
Closed Access
Hui Zhu, Kun Zhao
Ophthalmology (2025)
Closed Access
Avances farmacológicos en la lucha contra la obesidad
Pablo Caballero Portero
Panorama actual del medicamento (2025) Vol. 49, Iss. 481, pp. 154-182
Closed Access
Pablo Caballero Portero
Panorama actual del medicamento (2025) Vol. 49, Iss. 481, pp. 154-182
Closed Access
Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial
Søren Gullaksen, Liv Vernstrøm, Steffen S. Sørensen, et al.
Journal of Diabetes and its Complications (2025), pp. 109039-109039
Closed Access
Søren Gullaksen, Liv Vernstrøm, Steffen S. Sørensen, et al.
Journal of Diabetes and its Complications (2025), pp. 109039-109039
Closed Access
Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting
Tao Zhao, Liting Zheng, Yiyun Feng, et al.
BMC Ophthalmology (2025) Vol. 25, Iss. 1
Open Access
Tao Zhao, Liting Zheng, Yiyun Feng, et al.
BMC Ophthalmology (2025) Vol. 25, Iss. 1
Open Access
NAION risk with semaglutide: what we know so far
Alan Y. Hsu, Yu‐Hsun Wang, Chun‐Ju Lin, et al.
Eye (2025)
Closed Access
Alan Y. Hsu, Yu‐Hsun Wang, Chun‐Ju Lin, et al.
Eye (2025)
Closed Access
